Concepedia

Michel Héaulme

MH

Statistics

Publications

28

Citations

4.2K

H-Index

22

Active since

1980

Affiliations

Sanofi (France)(Current)

Centre National de la Recherche Scientifique

Inserm

Sorbonne Université

Hôpital Saint-Antoine

Michel Héaulme is an author at Sanofi (France) specializing in pharmacology, neuroscience, and neuropharmacology.

Publications per year

1980–2008

28

Publications

28

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters · 1994 · 1.8K citations · Full text

, , +14

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

D. Gully, M. Canton, Robert Boigegrain et al. · Proceedings of the National Academy of Sciences · 1993 · 415 citations

, , +16

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

Xavier Emonds‐Alt, Jean-Daniel Doutremepuich, Michel Héaulme et al. · European Journal of Pharmacology · 1993 · 374 citations

, , +5

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · Life Sciences · 1995 · 300 citations

, , +10

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne‐Bouhtou et al. · Neuropsychopharmacology · 2005 · 219 citations

, , +16

1–5 of 28